Golimumab
Term · Oncology and biomedicine · MLC-T-ONC-014003
A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.
| Identifier | MLC-T-ONC-014003 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | immunoglobulin G1, anti-(human Tumor Necrosis Factor Alpha) (human monoclonal CNTO 148 gamma-1-chain), disulfide with human monoclonal CNTO 148 kappa-chain, dimer |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014003",
"term": "Golimumab",
"field": "Oncology and biomedicine",
"definition": "A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing TNF-a-mediated immune responses. TNF-a production is dysregulated in various auto-immune diseases and in cancer.",
"synonyms": [
"immunoglobulin G1, anti-(human Tumor Necrosis Factor Alpha) (human monoclonal CNTO 148 gamma-1-chain), disulfide with human monoclonal CNTO 148 kappa-chain, dimer"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/golimumab/"
}
Record 8,112 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.